ag-1296 has been researched along with Demyelinating Diseases in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute demyelination of adult CNS, resulting from trauma or disease, is initially followed by remyelination." | 1.32 | PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. ( Armstrong, RC; Frost, EE; Le, TQ; Nielsen, JA, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frost, EE | 1 |
| Nielsen, JA | 1 |
| Le, TQ | 1 |
| Armstrong, RC | 1 |
1 other study available for ag-1296 and Demyelinating Diseases
| Article | Year |
|---|---|
PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination.
Topics: Animals; Animals, Newborn; Antibodies; Antigens; Cell Differentiation; Cell Division; Cell Lineage; | 2003 |